UK markets open in 2 hours

The Chemours Company (CC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
27.80+0.66 (+2.43%)
At close: 04:00PM EDT
27.58 -0.22 (-0.79%)
After hours: 06:40PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close27.14
Open27.30
Bid27.76 x 1100
Ask28.09 x 900
Day's range27.04 - 27.94
52-week range15.10 - 39.05
Volume1,792,686
Avg. volume1,898,808
Market cap4.127B
Beta (5Y monthly)1.97
PE ratio (TTM)N/A
EPS (TTM)-2.00
Earnings date25 Apr 2024 - 29 Apr 2024
Forward dividend & yield1.00 (3.60%)
Ex-dividend date23 Feb 2024
1y target est29.00
  • Business Wire

    Chemours Receives NYSE Notice Regarding Delayed Form 10-K Filing

    WILMINGTON, Del., March 18, 2024--Chemours Receives NYSE Notice Regarding Delayed Form 10-K Filing

  • Zacks

    Should Value Investors Buy Chemours (CC) Stock?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Reuters

    Chemours says top execs manipulated free cash flow, foresees no impact on results

    Chemours said on Wednesday that an internal review revealed its senior executives manipulated some vendor payments and collections of receivables in the fourth quarter of 2023 in part to meet free cash flow targets, tied to their incentives. The findings will not affect its preliminary results estimates for the year ended Dec. 31, the U.S. chemical company said, without disclosing a date to report its results. Chemours' shares plunged to a more than three-year low last week after it placed its top three executives, including CEO Mark Newman, on administrative leave and said it was looking into potential "material weaknesses" in its financial reporting.